RESEARCH DOSSIER
Enterprise Risk Management and Insurance Firm Value
Abstract. Enterprise risk management (ERM) in insurance is a coordinated organizational capacity for identifying, assessing, financing, limiting, and communicating risks across underwriting, reserving, investments, asset–liability management, liquidity, operations, strategy, and the insurance group. Its economic importance lies in the relationship between risk decisions, deployable capital, the cost of financial distress, the continuity of insurance services, and the present value of future distributable resources. This monograph examines whether, how, and under what conditions ERM relates to insurance firm value. It integrates corporate risk-management economics, insurer-specific capital theory, comparative supervisory instruments, and original empirical studies of United States and European insurers. Particular attention is given to the apparent disagreement between an approximately 20% valuation premium reported by Hoyt and Liebenberg (2011), the absence of incremental value from an advanced ERM rating in McShane, Nair, and Rustambekov (2011), and a roughly 6.5% valuation association in European insurers reported by Bohnert and colleagues (2019). The analysis establishes the precise interpretive limits of these estimates: exposure definition, legal entity, ownership form, selection, unobserved governance, simultaneous regulation, changes in accounting measurement, and market valuation all matter. It develops an evidence-grounded comparison of operational, capital, governance, and market-signaling channels and specifies empirical designs capable of separating adoption from effectiveness. ERM is potentially value-relevant through better joint risk acceptance and more credible financial resilience, while adoption indicators and reported premiums remain conditional observational evidence. The original contribution is a critical integration of the existing research and an operationally explicit evaluation agenda; no new scientific theory, doctrine, or proprietary model is proposed.
Keywords: Enterprise risk management; insurance firm value; risk-adjusted performance; insurer valuation; Tobin's Q; capital allocation; risk appetite; economic capital; own risk and solvency assessment; solvency; insurer governance; reinsurance; asset–liability management; causal identification; selection bias; risk culture; insurance regulation; shareholder value; policyholder security.
Introduction
The value of an insurance enterprise depends on its ability to accept uncertain obligations today and honor them over time while investing and preserving financial resources. Insurers receive premiums, invest assets, incur expenses, settle claims, and maintain capital against adverse outcomes. Their internal risk decisions interact through common loss drivers, counterparties, market prices, lapse behavior, operational dependencies, and sometimes correlated policyholder behavior. An apparently profitable underwriting expansion can require more capital, generate liquidity demands after catastrophe, and amplify credit or investment exposure at the group level. The economic object of ERM is therefore the coordinated set of decisions that connects these exposures to enterprise strategy.
This research addresses an empirical proposition with practical and theoretical significance: insurers with more mature ERM may command greater market valuations or achieve better risk-adjusted financial performance. The proposition is neither a mathematical inevitability nor a uniform claim across insurers. It can be true in one institutional setting, attenuated in another, and differently measurable for stock, mutual, reinsurer, and insurance-group entities. Published work supplies a particularly instructive comparison. The U.S. insurer analysis by Hoyt and Liebenberg (2011) reports an estimated ERM valuation premium of about 20%. Using Standard & Poor's assessments, McShane, Nair, and Rustambekov (2011) find value associated with greater conventional risk-management capability but no incremental gain from a more advanced ERM rating. A European insurer study by Bohnert and colleagues (2019) estimates a roughly 6.5% higher Tobin's Q for insurers with stronger risk-management ratings after the authors' stated adjustments.
These studies pose a specific scientific task: determine what each design measures before interpreting a numerical contrast as evidence about the same underlying causal effect. One study observes announced or inferred adoption, another an externally assessed rating, and another a different market and regulatory environment. The relevant treatment may be a governance reorganization, a change in risk limits, an improvement in execution, or simply a classification assigned to an insurer that already possessed strong controls. Differences in measured value may also arise from financial reporting and legal structure.
The principal scientific owner is the published Enterprise Risk Management in Insurance Science. The dossier draws on the associated published areas of Insurance Economics, Insurance Statistics and Predictive Modeling, and Insurance Finance and Asset-Liability Management. These relations delineate a valuation-focused inquiry rather than replacing specialized work on ORSA, economic capital, reinsurance pricing, stress testing, or model validation.
Methodologically, the work combines close reading of international principles, jurisdiction-specific rules, insurer-focused theoretical research, original empirical papers, and documented limitations of accessible insurance financial data. It interprets original statistical claims at the level available in the publisher abstracts and accessible manuscript records. Where full proprietary data, statistical code, or paywalled article tables were unavailable, this monograph makes no independent replication claim. The equations are standard valuation or statistical relations stated as analytical tools; illustrative calculations are explicitly hypothetical. The research horizon is November 14, 2026.
Definitions, History, and Documentary Foundations
The economic and organizational object
ERM is the system through which an insurer coordinates risk identification, risk appetite, exposures, risk responses, internal limits, capital assessment, and decisions across organizational functions. The IAIS Insurance Core Principles, especially ICP 16, describe an integrated framework for solvency purposes in which risk management, capital adequacy, and strategic planning operate together. The IAIS formulation makes policyholder protection and the continuing ability to fulfill insurance obligations explicit supervisory objectives. The relevant enterprise includes the insurer's aggregate positions and the relationships among risks, while each legal entity continues to matter for the enforceability of insurance obligations and capital transferability.
The conceptual category requires distinguishing three objects. First, risk-management activity consists of individual transactions or controls: purchasing reinsurance, limiting investment concentration, approving underwriting authority, or validating reserve assumptions. Second, an ERM framework organizes those activities through a consistent decision structure and governance. Third, effective ERM is a demonstrated improvement in choices, information flows, controls, capital deployment, or outcomes. The distinction matters because compliance with a documented policy is evidence of a control's existence; a change in realized losses or risk-adjusted value requires further evidence of function and effect.
The COSO 2017 ERM framework ties enterprise risk to strategy and performance. The cross-industry ISO 31000:2018 guidelines similarly situate risk management in decision-making, leadership, monitoring, and organizational processes. Both provide useful organizational vocabulary, whereas ICP 16 addresses the insurer's solvency-specific relationship among material exposures, capital, and insurance obligations. Neither general framework supplies an estimated valuation effect. A rigorous empirical study must operationalize implementation instead of equating the citation of a framework with evidence that decisions improved.
Historical development as evidence, not an adoption date
The integration of financial risk decisions preceded the adoption of the ERM label. Froot, Scharfstein, and Stein's investment-and-financing analysis established why risk management can have value when external capital is more costly than internal funds and investment opportunities depend on financing availability. In the insurance industry, Froot's insurer and reinsurer analysis subsequently placed underwriting, reinsurance, hedging, and surplus capital in an integrated economic discussion. Nocco and Stulz (2006), in their ERM practice and theory account, separated firm-wide control of exposures from decisions made by operating units and described a practitioner example from Nationwide Insurance.
This intellectual progression is analytically important. A modern ERM report might formalize practices already present for many years. If researchers date treatment from the appointment of a chief risk officer, a public annual-report statement, or a first ratings announcement, the recorded event can follow the substantive change. Conversely, an appointed risk officer may precede meaningful operational integration. The timing of a proxy is a measurement choice and a causal assumption.
Regulatory development has increased the availability of structured ERM records. In the European Union, the Solvency II risk-management requirements require ongoing identification and management of individual and aggregated risks and integration in the organizational structure and decisions. The associated ORSA requirement in Article 45 covers overall solvency needs, capital compliance, and departures from the assumptions underlying regulatory capital measurement. The EIOPA ORSA guidelines, published in 2015, help identify the framework's regulatory setting. Statutory requirements and supervisory guidance are distinct institutional instruments; neither alone establishes a market-value improvement.
In the United States, the NAIC's Risk Management and ORSA Model Act supplies a model for state-level implementation rather than a self-executing nationwide rule. The NAIC's 2026 ORSA Guidance Manual describes reporting about material risks, relevant controls, capital adequacy, and prospective solvency under applicable domestic state law. The NAIC ERM regulatory overview, updated October 26, 2026, documents the supervisory context and changes in guidance. These rules are evidence about expected institutional processes; the effect of such processes on shareholder value remains an empirical question.
Stakeholders and the definition of firm value
For a listed stock insurer, market valuation concerns the exchange value of claims on the company, ordinarily represented by market equity and appropriate debt measures. For a mutual insurer, a readily observed equity market price typically does not exist; surplus, costs, policyholder participation, service quality, claims capacity, and solvency become relevant but conceptually different performance indicators. A wholly owned insurance subsidiary may have statutory accounts and a solvency assessment while lacking any separate traded security. A publicly traded group may include insurance and other operations. The unit of analysis must therefore be stated before interpreting a firm-level value metric.
The normative objectives also differ. Shareholders have residual economic interests; policyholders hold contractual claims and depend on continued performance. Prudential regulators evaluate solvency, governance, and policyholder protection. An ERM action may sacrifice a marginal short-term underwriting opportunity to preserve policyholder security, liquidity, or long-term capacity. Whether it adds shareholder value depends on the prices, costs, future opportunities, and constraints involved. Increased capital safety may increase franchise durability while reducing measured short-term return on equity through a larger capital denominator. These are compatible accounting and economic observations.
ERM Adoption, Implementation, and Classification
Observable proxies and their content
ERM adoption is commonly measured by public disclosure, a chief risk officer or risk committee, risk-adjusted decision methods, formal economic capital models, self-reported survey responses, or an external rating. These proxies encode different dimensions. A chief risk officer indicator captures a role's presence but leaves authority, independence, and behavior to additional evidence. An ERM rating is a composite assessment that may recognize already successful internal practices. Survey results offer organizational detail but can suffer nonresponse and social desirability bias. Annual reports provide a searchable history but are influenced by disclosure incentives and changing regulatory requirements.
An empirically meaningful maturity assessment should therefore distinguish organizational presence, decision integration, and observed functioning. Organizational presence is evidenced by board mandates, named senior accountability, approved appetite statements, and consistent reporting. Decision integration requires that underwriting, investment, reinsurance, liquidity, and strategic planning incorporate risk-capital consequences into actual approvals. Functioning requires back-testing, limit monitoring, override documentation, incident escalation, credible scenario responses, and evidence that decisions changed when new information arrived. These distinctions refine the interpretation of existing indicators; they do not establish a proprietary ERM maturity scale.
Grace and colleagues (2015) examine the operational detail behind the label. Their study of ERM investment associates economic capital models and dedicated risk managers with improved insurer operating performance and reports that reporting to the board or chief executive is value-relevant. The findings address combinations of practices, and the authors' empirical evidence concerns a survey-based insurer sample. The result supports examining governance and risk information together, not treating possession of a risk manager as an individually proven causal intervention.
Enterprise scope and authority
The enterprise boundary deserves specific attention. A group may measure consolidated market risk while individual insurance subsidiaries face different restrictions on dividends, capital transfers, collateral, supervisory intervention, and policyholder claims. A group-level improvement in diversified risk may not release usable capital to a subsidiary under local ring-fencing rules. The economic impact depends on whether diversification can be recognized prudentially and whether cash and capital can move where losses or growth require them.
Authority is equally material. Effective central risk oversight requires information from business units but also the capacity to challenge a profitable-seeming transaction that generates an expensive concentration or liquidity tail. A risk committee can enhance shared information while creating delay or strategic vetoes. Risk limits can discipline underwriting but may be set too tightly when a specialized insurer possesses superior underwriting information. Implementation quality is observable in decisions around exceptions, escalation, and capital allocation; governance charts alone are incomplete.
The practical content of a risk appetite statement is set out in ICP 16's risk-appetite provisions, which connect aggregate risk-taking, capital, earnings, liquidity, and operational limits. In the Australian framework, APRA's CPS 220 standard requires board-approved risk appetite and risk management arrangements encompassing material insurance and strategic risks. These obligations provide documentary tests of the system's intended scope; they cannot validate the economic effectiveness of a particular insurer's implementation without observation of behavior and outcomes.
Adoption costs and implementation dynamics
ERM imposes direct costs: staff, systems, controls, internal models, data reconciliation, training, audit, and supervisory reporting. Indirect costs include managerial attention, friction in approvals, and the opportunity cost of more conservative risk limits. There may also be benefits from eliminating duplicative controls and shared reporting requirements. A credible financial analysis should use net effects over time and should not count a reduction in reported volatility twice as both an economic gain and a separate value premium when the premium already capitalizes that improvement.
Implementation evolves. An insurer may spend several years before risk data, capital models, business-unit incentives, and strategy become mutually consistent. If a study classifies the insurer as treated at the public launch of an ERM initiative, early returns can incorporate one-off implementation expenditures while benefits occur later. A static treatment indicator then averages distinct transition stages. A negative short-horizon result and positive long-horizon result may coexist without statistical contradiction. Conversely, an insurer that reports mature ERM may simply have adopted it long before observation, inviting survivor and left-truncation bias.
Value Outcomes and Risk-Control Mechanisms
A disciplined valuation relation
The economic value of an insurer's shareholders can be expressed, under a consistent valuation basis, as the present value of prospective distributable cash flows after fulfilling contractual obligations and maintaining sufficient capital. For a simplified finite horizon, write the standard discounted-cash-flow relation as
where is the distribution available to owners after policyholder claims, operating costs, investments and capital requirements, denotes an appropriate discount rate or a notational shorthand for the applicable term structure, and is terminal residual value. The expression is a valuation illustration, not a newly derived or empirically calibrated pricing model. When cash flows and discount rates vary jointly with market states, a full state-price or stochastic-discount-factor treatment is required; a simple expectation at a fixed discount rate is only an approximation under additional assumptions.
ERM can affect this relation through the distribution and timing of cash available after losses, the costs of financing, access to profitable underwriting opportunities, customer and distribution relationships, and the riskiness of residual claims. A fall in total volatility is neither necessary nor sufficient for an increase in market value. Diversifiable volatility may not be priced directly in frictionless financial markets; insurer-specific financial frictions, costly distress, agency problems, taxes, contract confidence, and financing constraints provide relevant mechanisms.
The general financing argument in Froot, Scharfstein, and Stein (1993) and the insurer-specific integration in Froot (2007) explain why underwriting, investment, hedging and capital decisions must be jointly evaluated. For an insurer, costly contingent capital may make a reinsurance purchase valuable even when the ceded expected loss is smaller than the reinsurance premium. The purchase can protect future underwriting capacity, preserve credit standing, or reduce insolvency-related costs. The relevant net value accounts for reinsurance margin, basis risk, recoverables, collateral, and the availability of alternative capital.
Underwriting, reserving and strategic capacity
An integrated view of risk changes underwriting appetite by considering the marginal contribution of a contract or portfolio to aggregate risk instead of using standalone expected loss alone. For example, an insurer may accept a new peril with higher standalone volatility if its claims are weakly associated with existing capital stress scenarios, while declining an apparently profitable concentration in the same catastrophe zone. The decisive distinction is between marginal portfolio risk and isolated line-of-business performance.
Reserving and claims practices also carry value consequences. A systematic reserve shortfall may artificially inflate short-run earnings while forcing future capital injections and weakening market confidence. ERM can improve the challenge process around actuarial assumptions and the consistency of pricing, claims, and reserve scenarios. Yet reserve strengthening can immediately reduce reported earnings; a simultaneous fall in market value does not prove that improved risk oversight destroyed economic value. The event's information content, cash-flow consequences, and previously undisclosed risk have to be separated.
Enterprise assessment is especially relevant when a long-tailed insurance liability and asset portfolio respond to common interest-rate, inflation, currency, and credit shocks. Asset–liability management can protect solvency against mismatched cash flows; inappropriate duration hedging can consume liquidity or fail to match insurance liability behavior. Reinsurance creates risk transfer and counterparty exposures simultaneously. These tradeoffs show why a purely functional, contract-by-contract analysis can understate the interactions addressed by ERM.
Distress, capital, and financing costs
Insurance enterprises maintain solvency resources because claim obligations are uncertain and losses can exhaust assets. ERM can reduce the probability or severity of adverse financial states by controlling correlated exposures, choosing retention, or prearranging liquidity. A lower distress probability may preserve the insurer's ability to renew business, negotiate reinsurance, finance acquisitions, and retain intermediaries. The potential benefit is greatest when distress imposes significant indirect costs and alternative financing cannot arrive promptly.
Risk capital has two different interpretations. Regulatory capital is measured under prescribed jurisdictional standards; internal economic capital is an insurer's chosen probabilistic or scenario-based assessment under stated objectives, horizons, and risk measures. Reductions in a modeled internal risk measure are not automatically releases of regulatory capital. Likewise, correlations assumed in a model can create apparent diversification benefits that fail in catastrophe or systemic crisis. Capital efficiency claims require reconciliation between model output, legal-entity constraints, stress losses, and genuinely distributable resources.
Consider a purely hypothetical insurer that expects a permanent $5 million annual net improvement in cash available for distribution after full incremental ERM costs. If the improvement is certain, permanent, and valued at a constant 8% annual discount rate, the stylized present value is $5 million / 0.08, or $62.5 million. This arithmetic demonstrates that even modest recurring net cash-flow changes can be economically meaningful. It is not a forecast for any insurer: finite policy maturities, varying premiums, correlated discount rates, insurer taxes, capital restrictions, implementation delays, and uncertainty break the simple perpetuity assumptions.
Market confidence and governance information
A public ERM designation may also convey information about management quality, risk discipline, and the credibility of reserve and solvency representations. A market response around an external assessment can therefore represent newly disclosed information about existing capability rather than an instantaneous productivity improvement. These channels have different policy implications. If credible risk information improves prices, transparency matters; if internal execution improves expected financial outcomes, organizational implementation matters. Both can occur, but a single observed stock return cannot assign the proportion attributable to each without an identification strategy.
Baxter and colleagues' study of ERM program quality reports that higher-rated financial-services firms have better accounting performance and that markets respond to rating-related information. It also describes differing return patterns during the financial crisis and recovery. The study includes financial institutions beyond an exclusive insurance sample, so its valuation mechanism informs the dossier without furnishing an insurer-only causal estimate. The contrast between market information and underlying economic effectiveness is a major reason to avoid interpreting a rating announcement as proof that governance reform itself created the observed value.
Stakeholder and system-level consequences
Insurer value and policyholder security can be aligned when ERM supports credible claim payment, predictable underwriting capacity, and lower distress costs. They can also be evaluated through different objective functions. A profitable but excessive transfer of risk to policyholders, counterparties, or government guarantees could raise private returns while increasing external expected losses. Prudential ERM under IAIS ICP 16 explicitly connects risk management with the insurer's capacity to meet policyholder obligations. A scientifically complete value assessment thus reports the shareholder-value measure and relevant solvency or policyholder indicators separately.
Empirical Evidence and Causal Identification
The principal insurer valuation studies
The best-known U.S. insurer estimate is the approximately 20% value premium in The Value of Enterprise Risk Management by Hoyt and Liebenberg (2011). The investigators seek to identify ERM implementation and jointly model its determinants and the value outcome proxied by Tobin's Q. Their result is statistically and economically meaningful within the paper's specification. Its interpretation remains an observational estimate: the reported premium is a difference conditional on measured covariates and structural assumptions, not a guaranteed 20% gain for an insurer that institutes an ERM department.
Does Enterprise Risk Management Increase Firm Value? by McShane, Nair, and Rustambekov (2011) studies insurers using Standard & Poor's risk-management ratings. It reports a positive relationship between greater traditional risk-management capability and firm value but does not find an additional value increment for the more advanced ERM rating category. The result has substantive force precisely because it distinguishes a rating gradient from the existence of traditional practices. An insurer can benefit from accurate pricing, hedging, reserve oversight, and controls while the incremental cross-enterprise label contributes little additional observable value in that sample.
In a European context, Bohnert, Gatzert, Hoyt, and Lechner's study of ERM ratings finds that insurers with high-quality risk management are associated with an average Tobin's Q about 6.5% higher than lower-rated counterparts after the authors' controls and treatment of endogeneity. The reported 6.5% is neither a direct replication of the U.S. 20% nor an estimate of exactly the same counterfactual treatment. Sample composition, regulation, dates, rating categories, markets, and model specification differ. The reported adjustment for endogeneity strengthens the analysis according to its assumptions but does not erase all possible omitted variables or guarantee a policy-invariant effect.
The combined lesson is evidence heterogeneity. The estimands differ. For Hoyt and Liebenberg, ERM presence or inferred adoption is central. For McShane and colleagues, the contrast concerns rating capability levels, including the incremental contribution of higher ERM classification. For Bohnert and colleagues, the comparison is between degrees of rating quality among European insurers. A pooled headline of approximately 20%, 0%, and 6.5% would be misleading unless the researcher harmonized treatment, outcome, period, unit and identification assumptions. The studies should instead be read as separate conditional tests of related but distinct questions.
Evidence from implementation and broader financial institutions
Grace, Leverty, Phillips, and Shimpi (2015) emphasize concrete practices. Their insurer study finds that the use of economic capital models, dedicated risk managers, and reporting relationships to the board or chief executive are associated with operating performance. This is more operationally informative than a single adoption dummy because organizational combinations can matter. Nevertheless, the same management quality, resources, or culture that make ERM effective can influence financial results directly. Selection into organizational features remains a central challenge.
Baxter and colleagues (2013) examine ERM quality in financial-service companies and find associations with governance, accounting performance, and market responses. Their financial-crisis evidence reports no superior market performance before or during the market collapse and higher returns for stronger-ERM firms during the rebound. A result that varies across market states is plausible for systems designed to manage adverse scenarios and financing continuity. Yet it may also reflect the composition, capitalization, and business models of firms that received higher ratings. The crisis context alone does not create random treatment.
The cross-industry analysis by Gordon, Loeb, and Tseng (2009) finds that the relationship between ERM and performance depends on organizational and environmental conditions, including uncertainty, industry competition, size, complexity, and board monitoring. It uses a sample of firms with SEC-disclosed ERM activity, not a global insurer population. Its direct contribution to this dossier is evidence against assuming a universal constant ERM effect and guidance about likely interaction variables, rather than a standalone insurance-specific value estimate.
Selection, reverse causality and confounding
An empirical correlation between ERM and market value can arise through several causal paths. A stronger insurer may be able to afford advanced modeling and specialized risk personnel. A board with better governance may establish ERM and independently improve underwriting discipline. A group entering new markets may adopt ERM and simultaneously expand profitable business. A supervisor may require additional processes after an insurer's risk profile deteriorates, generating a negative pre-adoption trend. Conversely, an insurer may disclose ERM precisely to reassure markets following a loss event.
Let denote a measured ERM indicator for insurer at time , its market or financial outcome, observed determinants, and unobserved management quality or risk environment. A common observational specification is
The insurer effects absorb time-invariant insurer characteristics and common date shocks. A causal interpretation of still requires assumptions about the absence of relevant unmeasured time-varying confounding, correct outcome timing, and the stability of treatment measurement. Including current profitability, risk exposures, or capital ratios as controls can create post-treatment bias if ERM itself affects them. A confounder must be identified conceptually rather than automatically entered because it predicts the outcome.
A second issue is simultaneously determined market valuation and risk management. A high market-to-book insurer may experience financing conditions that improve ERM resources, while ERM may change perceived quality and hence market valuation. Simultaneous-equation corrections, instrumental variables, or selection models may reduce a stated class of endogeneity under their respective identifying assumptions. An instrument that is associated with regulation, credit ratings, or governance can affect value through channels other than ERM and violate the exclusion restriction. Statistical significance does not validate an instrument's economic exclusion argument.
Evaluation designs and their limits
A stronger prospective study would establish a dated implementation timeline from board decisions, capital committee records, regulator filings, risk limits, reinsurance placements, and business-unit process changes. It would then compare the insurer's outcome trend before and after changes with credible comparison insurers, controlling for concurrent shocks. Dynamic event-study coefficients would help show whether a claimed post-adoption result began before implementation. With staggered adoption, methods should accommodate heterogeneous effects and avoid inappropriate aggregation of already-treated firms as controls.
Difference-in-differences can estimate a treatment effect under suitable conditional parallel trends and stable comparison conditions, but regulation-driven adoption can violate these premises if exposed insurers face different shocks. Matching on size, product mix, jurisdiction, capitalization, or prior ratings improves observed similarity but cannot resolve selection on unmeasured governance or future strategy. Regression discontinuity around a regulatory threshold might identify a local compliance effect only if firms cannot manipulate the assignment variable, there are enough comparable insurers, and the threshold changes ERM exposure without unrelated value-relevant requirements. In U.S. research, the legal adoption of Model 505 must be verified for each state and year before constructing such a design.
An announcement event study can detect short-window market-information effects. It is less suited to measuring long-run changes in underwriting, reserve quality, or capital efficiency. ERM ratings may be announced alongside other rating information, a merger, or earnings guidance, confounding the event window. A finding that a rating update affects stock price is evidence about investors' response to news under the event-study assumptions, not a direct estimate of the return from constructing the ERM system.
Data architecture and reproducibility
An insurer-focused dataset must distinguish the ultimate holding group from licensed underwriting entities and identify mergers, demutualizations, cross-border subsidiaries, and changed reporting conventions. The NAIC Financial Data Repository describes annual and quarterly statutory insurance financial filings, including risk-based-capital reporting. Access to the underlying observations and the permissible publication of confidential ORSA information are separate matters; this study does not claim to possess individual insurer data or private ORSA reports.
A credible replicable panel would record data sources, legal-entity and holding-group maps, an ERM treatment history, insurer type, ownership, jurisdiction, premium volume, losses, reserve development, reinsurance dependence, investment duration, catastrophe exposure, capital adequacy, external ratings, and accounting rules. It should specify how discontinued insurers and mergers enter the sample. Restricting observations to surviving listed insurers can select away exactly the distress events ERM is intended to affect. An insurer with no stock-market value requires a distinct outcome and cannot silently enter a Tobin's-Q regression through an invented proxy.
Sensitivity, Heterogeneity, and Measurement
Measuring firm value with consistency
Tobin's Q and its approximations typically relate a firm's market value to the replacement cost or an accounting proxy for the asset base. A common empirical approximation uses market equity and the book value of debt relative to book assets. Its implementation varies; it can be especially difficult for insurers whose liabilities represent long-term contractual promises rather than ordinary nonfinancial corporate debt. An author must reproduce the paper's exact formula before comparing numerical premia across studies.
Three measures answer different questions. Market value captures expectations and the market pricing of residual risks. Accounting profitability captures period performance under a chosen recognition and valuation framework. Solvency measures capital available or required under specified regulatory rules or internal models. A market premium may exist without a contemporaneous ROA improvement, because expected benefits lie in future risk resilience. A near-term ROA gain may coexist with poor stress resilience when earnings result from unusually favorable realized losses. Regulatory solvency improvement may impose present opportunity costs yet enhance long-horizon franchise value.
Comparability also changes with accounting standards. The IFRS Foundation's IFRS 17 Insurance Contracts became effective for annual reporting periods starting January 1, 2023 (subject to its application rules). Its treatment of insurance fulfillment cash flows, risk adjustments, contractual service margin, and presentation changes the relation between reported revenue, earnings and balance-sheet liabilities. A panel that crosses implementation dates should not interpret mechanically altered metrics as ERM-created value. U.S. statutory accounting and other local regimes require their own bridges. In a cross-country comparison, a transformed outcome must be defined and justified before estimating a common coefficient.
Heterogeneity across business models
The value of ERM is contingent on the exposures an insurer can control and the financial frictions it faces. Long-duration life insurance includes interest-rate, policyholder behavior, guarantee, and asset–liability risks. Property and casualty insurance includes catastrophe aggregation, claims inflation, reserving, reinsurance credit, and underwriting-cycle risks. Reinsurers may specialize in globally correlated tail exposures while having more flexible risk transfer opportunities. Health and specialized insurers introduce medical utilization, provider concentration, regulatory pricing, and operational dependencies. The same nominal ERM practice may have different marginal value in each business.
A life insurer using economic capital to govern guarantees may improve asset–liability decisions, while a property insurer may gain more from correlated catastrophe accumulation and reinsurance retention optimization. Grace and colleagues' insurance ERM findings identify economically relevant differences in the use of models, including a stronger reported benefit from economic capital tools for life insurers in their studied setting. Such findings motivate interaction tests by business line and model purpose; they do not establish a globally stable ranking of insurer types.
Firm size, complexity, and existing management quality also change marginal benefits. A small specialist with simple liabilities may have sufficient integrated risk knowledge through a compact leadership team; an elaborate program may add cost. A large group may benefit from unified concentration information and capital coordination, but its complicated internal reporting creates implementation risks. A weakly governed firm may receive a larger potential improvement from basic controls than from sophisticated modeling. This is consistent with Gordon and colleagues' contingency evidence and with the absence of incremental value for higher ratings found in one U.S. rating study. The relevant comparator is the actual marginal addition beyond existing risk practice.
Sensitivity to risk states and observation horizons
Annual mean profitability can be an inadequate test of a system whose principal benefit is resilience to infrequent severe states. A high-quality ERM program may permit a firm to avoid forced liquidation or preserve underwriting capacity after an adverse event; the benefit may emerge only in lower quantiles of performance or during recovery. Stress-specific analysis should therefore consider claims settlement, capital markets access, liquidity, rating migration, and changes in underwriting capacity as well as stock returns. The financial-crisis findings of Baxter and colleagues illustrate the importance of specifying the crisis stage rather than assigning one timeless crisis effect.
Sensitivity checks should use plausible alternative treatment dates, categorical and continuous maturity proxies, lag structures, balanced and unbalanced insurer samples, peer groups, risk exposure controls, country–year effects, and alternative valuation and operating outcomes. Estimates should be reported with intervals and units, and should explain how missing disclosure and nonresponse were handled. The aim is to determine which mechanisms persist under reasonable decisions, not to select the specification producing the largest premium.
The 20% and 6.5% figures cited earlier require particular discipline. They cannot be averaged as two interchangeable estimates of a global ERM effect: their outcome construction, sample markets, measurement and identifying assumptions differ. A meta-analysis that ignored these differences would create spurious precision. Even if a future harmonized analysis produced a statistically significant pooled estimate, applicability to unlisted mutual insurers and thinly capitalized national markets would remain a separate external-validity question.
Sensitivity to reporting and information
Disclosure intensity can be correlated with governance, investor relations capacity, and pressure from analysts. An insurer that reports detailed ERM may be easier for researchers to classify even when another insurer conducts equivalent risk analysis privately. External ratings likewise depend on available information and the rating agency's scoring structure. A study should separate the economic treatment of better control from the information treatment of better disclosure. Where possible, documents should be linked to actual risk limits, committee actions, and capital decisions, not just the occurrence of a keyword.
ERM reporting may also improve after a loss, enforcement action, or management transition. If that improvement is coded as treatment, results can reflect mean reversion or a changing risk environment. Pre-event outcome histories, negative controls, and alternative event dates offer useful diagnostic evidence. There is no fully automatic econometric correction for inaccurate implementation histories; substantive documentary research is part of identification.
Comparative Synthesis and Research Implications
International prudential architecture
The IAIS solvency-oriented ERM standard creates a common international supervisory vocabulary while leaving national and regional implementation to relevant authorities. The European Article 44 risk-management system and Article 45 ORSA impose obligations within Solvency II. In the United States, the NAIC Model Act 505 and 2026 ORSA manual operate through the applicable state-based regulatory framework. Australia's CPS 220 adds a prudential structure for board governance, risk appetite, risk management strategy and business planning.
These institutional systems support comparative research, but they do not constitute a single homogeneous regulatory treatment. Legal force, legal-entity application, group supervision, exemptions, reporting confidentiality, capital methodology, timing, and enforcement vary. The analyst should establish what changed for whom and when. A post-reform rise in an insurer's valuation may coincide with altered accounting, investment-market conditions, or capital requirements. An ERM-compliance event is not automatically isolated from the surrounding solvency reform.
For policyholders, the first evaluative question concerns the capacity to meet obligations under the risks assumed. For supervisors, the relevant questions include whether risk appetite, risk identification, capital assessment, and oversight are credible and integrated. For equity investors, the question concerns the discounted value of future residual cash flows. These evaluations overlap, yet their performance metrics should retain distinct labels and denominators. A governance improvement can be economically useful despite a neutral immediate stock-market response.
A source-grounded reconciliation of the apparent contradiction
The three headline empirical findings can be reconciled analytically without discarding any observation. The Hoyt–Liebenberg estimate tests a broad ERM-associated valuation distinction within a U.S. insurer design. The McShane–Nair–Rustambekov result tests whether higher ERM ratings add a further increment beyond increasing conventional risk-management capability. The Bohnert–Gatzert–Hoyt–Lechner result relates European insurer ratings to valuation under a different market and supervisory environment. These are related questions with nonidentical contrasts. Strong elementary risk management may account for much of the measured value in one sample, while adoption or comprehensive quality indicators correlate with value in others.
This reconciliation is an interpretive reading of the literature, not proof that all studies identify one underlying causal curve. There is no observed common longitudinal treatment history, no harmonized cross-study estimating equation, and no independent insurer-level data replication in this dossier. The appropriate conclusion is conditional: integrated risk decisions can have economic value where they affect financing frictions, resource allocation, policyholder confidence or risk-taking behavior, and the empirical amount attributable to ERM requires design-specific identification.
An important implication concerns quality assessment. A formal ERM rating can be a measure of management ability, a signal to markets, a proxy for existing capital strength, and a description of internal processes simultaneously. Its coefficient in a market-value regression cannot, by itself, distinguish these roles. Better data and sharper designs should prioritize that distinction over mechanically adding more controls or importing percentage estimates from another jurisdiction.
A research agenda capable of testing mechanisms
A rigorous next empirical project should predefine the unit of observation, the period, the applicable reporting regime, and the primary estimand. At minimum, it should construct insurer-group and legal-entity mappings; determine when specific risk practices became operational; record the relevant rating history and disclosures; and select economic outcomes distinct from the components used to assign ERM ratings. Source records should make the treatment auditable. A mixed evidence design combining insurer board-level documentation, audited statements, regulatory changes, and market data is preferable to a keyword-only adoption classifier.
The evaluation should distinguish three separate outcomes: the effect of adopting formal governance, the effect of actually changing risk acceptance and capital decisions, and the market-information effect of outsiders learning that controls are stronger. Where treatments occur gradually, a dynamic event design with pretrend diagnostics and appropriate heterogeneous-effect estimators can be considered. Where no credible quasi-experiment exists, the result should remain a carefully bounded association.
Risk outcomes should include more than a mean performance measure. Relevant tests include reserve development, capital shortfalls, liquidity pressure, reinsurance recoverable stress, concentrated catastrophe exposure, rating migration, distribution capacity, and recoveries after shock. The reliability of these tests depends on access to the underlying data and the comparability of risk portfolios. Private ORSA summaries and proprietary risk models should not be claimed as independently verified when they are unavailable.
Scientific conclusions from the synthesis
Five findings follow from the reviewed evidence. First, ERM has well-specified economic pathways to value under insurer financing and product-market frictions. Second, organizational presence, quality ratings, and changed business decisions are different explanatory variables. Third, published insurer valuation results are heterogeneous and their percentage estimates are not mutually substitutable. Fourth, insurer valuation, accounting profitability, and policyholder security require separate outcome definitions. Fifth, the strongest future research design links implementation histories to operational choices, financial outcomes, and credible counterfactuals while respecting jurisdiction-specific supervision and accounting.
The synthesis offers a discipline for interpreting evidence rather than a universal ERM premium. The empirical proposition that ERM is valuable becomes answerable when treatment, unit, horizon, mechanism, outcome, and identification assumptions are made explicit. Without those specifications, a broad positive association can be informative but cannot justify a numerical claim about what any individual insurer will gain from an ERM investment.
Conclusion
Enterprise risk management can influence the economic value of an insurance enterprise through its effect on coordinated underwriting and investment decisions, the availability and cost of financial capital, risk transfer, liquidity, governance credibility, and the continuation of insurance services under adverse states. Its theoretical relevance is grounded in established corporate-finance and insurer-capital research, and its institutional relevance is reflected in IAIS, European, U.S., and Australian supervisory requirements. The presence of an ERM framework creates a structure for these decisions; the actual economic outcome depends on implementation, incentives, the firm's exposure structure, financial constraints, and its previous level of risk-management capability.
The principal empirical studies do not establish a single transferable value premium. Hoyt and Liebenberg report a substantial positive association for a U.S. insurer treatment definition; McShane, Nair, and Rustambekov find no additional rating premium beyond higher traditional risk-management capability; Bohnert and colleagues report a smaller positive European association. Their results illuminate different measurement choices and environments. Their reconciliation requires attention to selection, reverse causality, disclosure, rating construction, accounting change, and the distinction between shareholder value and policyholder security.
The scientific judgment of this monograph is that an insurer's ERM should be evaluated through the actual marginal improvement in risk-adjusted decisions and prospective financial resilience under its institutional constraints. That judgment is an original evidence-based synthesis, not a newly named theory or an assertion that the available observational studies identify a common causal effect. Research progress depends on linking dated practices, decision authority, capital and risk outcomes, comparable valuation metrics, and transparent counterfactual designs. These requirements provide a defensible foundation for international inquiry into enterprise risk management and insurance firm value.
References
Australian Prudential Regulation Authority. (2019). Prudential Standard CPS 220: Risk Management (effective July 1, 2019). APRA. https://www.apra.gov.au/standards/cps-220
Baxter, R., Bedard, J. C., Hoitash, R., & Yezegel, A. (2013). Enterprise risk management program quality: Determinants, value relevance, and the financial crisis. Contemporary Accounting Research, 30(4), 1264–1295. https://doi.org/10.1111/j.1911-3846.2012.01194.x
Bohnert, A., Gatzert, N., Hoyt, R. E., & Lechner, P. (2019). The drivers and value of enterprise risk management: Evidence from ERM ratings. The European Journal of Finance, 25(3), 234–255. https://doi.org/10.1080/1351847X.2018.1514314
Committee of Sponsoring Organizations of the Treadway Commission. (2017). Enterprise risk management—Integrating with strategy and performance. COSO. https://www.coso.org/guidance-erm
European Insurance and Occupational Pensions Authority. (2015). Guidelines on own risk solvency assessment (ORSA) (published September 14, 2015). EIOPA. https://www.eiopa.europa.eu/publications/guidelines-own-risk-solvency-assessment-orsa_en
European Insurance and Occupational Pensions Authority. (n.d.-a). Risk management: Solvency II Directive, Article 44. Solvency II Single Rulebook. https://www.eiopa.europa.eu/rulebook/solvency-ii-single-rulebook/article-2127_en
European Insurance and Occupational Pensions Authority. (n.d.-b). Own risk and solvency assessment: Solvency II Directive, Article 45. Solvency II Single Rulebook. https://www.eiopa.europa.eu/rulebook/solvency-ii-single-rulebook/article-2128_en
Froot, K. A. (2007). Risk management, capital budgeting, and capital structure policy for insurers and reinsurers. Journal of Risk and Insurance, 74(2), 273–299. https://doi.org/10.1111/j.1539-6975.2007.00213.x
Froot, K. A., Scharfstein, D. S., & Stein, J. C. (1993). Risk management: Coordinating corporate investment and financing policies. The Journal of Finance, 48(5), 1629–1658. https://doi.org/10.1111/j.1540-6261.1993.tb05123.x
Gordon, L. A., Loeb, M. P., & Tseng, C.-Y. (2009). Enterprise risk management and firm performance: A contingency perspective. Journal of Accounting and Public Policy, 28(4), 301–327. https://doi.org/10.1016/j.jaccpubpol.2009.06.006
Grace, M. F., Leverty, J. T., Phillips, R. D., & Shimpi, P. (2015). The value of investing in enterprise risk management. Journal of Risk and Insurance, 82(2), 289–316. https://doi.org/10.1111/jori.12022
Hoyt, R. E., & Liebenberg, A. P. (2011). The value of enterprise risk management. Journal of Risk and Insurance, 78(4), 795–822. https://doi.org/10.1111/j.1539-6975.2011.01413.x
IFRS Foundation. (2017, amended 2020). IFRS 17 Insurance Contracts (effective for annual reporting periods beginning on or after January 1, 2023). IFRS Foundation. https://www.ifrs.org/issued-standards/list-of-standards/ifrs-17-insurance-contracts/
International Association of Insurance Supervisors. (2024). Insurance Core Principles and Common Framework for the Supervision of Internationally Active Insurance Groups (ComFrame), adopted December 2024 (especially ICP 16). IAIS. https://www.iais.org/uploads/2024/12/IAIS-ICPs-and-ComFrame-adopted-in-December-2024.pdf
International Organization for Standardization. (2018). ISO 31000:2018: Risk management—Guidelines (2nd ed.). ISO. https://www.iso.org/standard/31000
McShane, M. K., Nair, A., & Rustambekov, E. (2011). Does enterprise risk management increase firm value? Journal of Accounting, Auditing & Finance, 26(4), 641–658. https://doi.org/10.1177/0148558X11409160
National Association of Insurance Commissioners. (2025). Financial Data Repository (updated June 2, 2025). NAIC Insurance Topics. https://content.naic.org/insurance-topics/financial-data-repository
National Association of Insurance Commissioners. (2026). Enterprise risk management (updated October 26, 2026). NAIC Insurance Topics. https://content.naic.org/insurance-topics/enterprise-risk-management
National Association of Insurance Commissioners. (2026). Own Risk and Solvency Assessment (ORSA) Guidance Manual, 2026 edition. NAIC. https://content.naic.org/sites/default/files/inline-files/orsa-guidance-manual-2026-final-posted-version_0.pdf
National Association of Insurance Commissioners. (n.d.). Risk Management and Own Risk and Solvency Assessment Model Act (Model 505). NAIC. https://content.naic.org/sites/default/files/model-law-505.pdf
Nocco, B. W., & Stulz, R. M. (2006). Enterprise risk management: Theory and practice. Journal of Applied Corporate Finance, 18(4), 8–20. https://doi.org/10.1111/j.1745-6622.2006.00106.x